February 18, 2026 · Form 4 insider transaction
Khattar Jack A. bought 341,610 shares of Supernus Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
The option vests in four equal annual installments beginning on February 18, 2027.